About the Authors
- David H Molyneux
- Peter J Hotez
*To whom correspondence should be addressed. E-mail: email@example.com
- Alan Fenwick
DHM is supported by the UK Department for International Development and GlaxoSmithKline (London, United Kingdom) and participates in the Mectizan Expert Committee/Albendazole Coordination meetings, which are supported by Merck and Company (Whitehouse Station, New Jersey, United States of America) and GlaxoSmithKline. JH is an inventor on an international patent application (PCT/US02/33106; filed 11 November, 2002) entitled “Hookworm Vaccine.” PJH is also Co-Chair of the Scientific Advisory Council of the Sabin Vaccine Institute (New Canaan, Connecticut, United States of America) and a member of the Academic Advisory Board for the Pfizer Fellowships in Infectious Diseases. AF is Director of the Schistosomiasis Control Initiative, which is supported by the Bill and Melinda Gates Foundation (Seattle, Washington, United States of America).